Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4/MyD88/NF-κB Signaling Pathway and Gut Microbiota

Epithelial Toll-like receptors and their role in gut homeostasis and disease

(2020) Juan F. Burgueño et al.   Nature Reviews Gastroenterology & Hepatology

Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels

(2020) Mohammad Tauqeer Alam et al.   Gut Pathogens

Comparison of the anti-colitis activities of Qing Dai/Indigo Naturalis constituents in mice

(2020) Kei Ozawa et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis

(2020) Amanda Ricciuto et al.   CLINICAL IMMUNOLOGY

A comprehensive review and update on ulcerative colitis,

(2019) Mahesh Gajendran et al.   DM DISEASE-A-MONTH

Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis

(2019) Yusuke Yoshimatsu et al.   DIGESTION

Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series

(2019) Jun Urushikubo et al.   INTERNAL MEDICINE

Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study

(2019) Makoto Naganuma et al.   JOURNAL OF GASTROENTEROLOGY

Short‐term and long‐term outcomes of indigo naturalis treatment for inflammatory bowel disease

(2019) Yuichi Matsuno et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community

(2019) Yan-Ni Liang et al.   MOLECULES

Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway

(2018) Xiao Cheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Probiotic Species in the Modulation of Gut Microbiota: An Overview

(2018) Md. Abul Kalam Azad et al.   Biomed Research International

Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-κB, blocking the TLR4 pathway and reducing ROS generation

(2018) Shin Kim et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Gut microbiome structure and metabolic activity in inflammatory bowel disease

(2018) Eric A. Franzosa et al.   Nature Microbiology

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

Anti-inflammatory and anti-apoptotic effects of the combination of Ligusticum chuanxiong and Radix Paeoniae against focal cerebral ischaemia via TLR4/MyD88/MAPK/NF-κB signalling pathway in MCAO rats

(2017) Junfei Gu et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Steppogenin Isolated from Cudrania tricuspidata Shows Antineuroinflammatory Effects via NF-κB and MAPK Pathways in LPS-Stimulated BV2 and Primary Rat Microglial Cells

(2017) Dong-Cheol Kim et al.   MOLECULES

Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis

(2017) Yunliang Wang et al.   Experimental and Therapeutic Medicine

Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells

(2016) Wenyan Gao et al.   ACTA HISTOCHEMICA

Ulcerative Colitis Is Characterized by a Decrease in Regulatory B Cells

(2016) Xinrui Wang et al.   Journal of Crohns & Colitis

Qing Dai attenuates nonsteroidal anti-inflammatory drug-induced mitochondrial reactive oxygen species in gastrointestinal epithelial cells

(2015) Rie Saito et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Proteobacteria: microbial signature of dysbiosis in gut microbiota

(2015) Na-Ri Shin et al.   TRENDS IN BIOTECHNOLOGY

Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease

(2015) Tarun Rai et al.   Gastroenterology Report

The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead

(2014) Aleksandar D. Kostic et al.   GASTROENTEROLOGY

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

(2014) Sara Renna   WORLD JOURNAL OF GASTROENTEROLOGY

Top-Down or Step-Up Treatment in Crohn's Disease?

(2013) Gerhard Rogler   DIGESTIVE DISEASES

Qing Hua Chang Yin exerts therapeutic effects against ulcerative colitis through the inhibition of the TLR4/NF-κB pathway

(2013) XIAO KE et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis

(2011) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

(2011) Alan W Walker et al.   BMC MICROBIOLOGY

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY